Developed in collaboration with REPROCELL, CELLvo ™ Atrial Cardiomyocyte delivers non-genetically modified human heart cells that are chamber specific and derived from iPS (stem) cells SAN ANTONIO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback